Now while we wait for RXMD and NXPL to make their move, go take a look at VCNX. It’s certainly not without risk, but I have a real feeling something is going too happen real soon with this stock.
Ok the risk, running out of money and Nasdaq non compliant I think by end of September, so does not sound great.
Positive note, recent data for its Alzheimer’s drug looked pretty good, and insiders just bought a lot of shares. Recent PR talked about a development partnership, and last insider buy was August 13th, so I believe we could potentially hear something after the insider purchase rule expires which I think is sometime mid to end of next week.
It has a super low share count with most owned by insiders of institutions, and float is minuscule.
Shares have started moving north again after quite sometime dropping.
Go take a look.
News 
Market Data 
Discover 
AI
